Global Oxygen Therapy Market Size study, by Product (Oxygen Source Equipment, Oxygen Delivery Devices), by Application (Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome and Others), by End-Use (Hospital

Global Oxygen Therapy Market Size study, by Product (Oxygen Source Equipment, Oxygen Delivery Devices), by Application (Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome and Others), by End-Use (Hospitals and Home Healthcare) and Regional Forecasts 2022-2028

Global Oxygen Therapy Market is valued at approximately USD XX Billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Oxygen Therapy is preferred by patients as a treatment option for those who are unable to get enough oxygen in their bodies. The increasing number of cases of asthma and other respiratory issues is one of the major factors driving market growth as Oxygen Therapy is used to treat asthma. According to the Centers for Disease Control and Prevention, the mortality rate due to asthma in the US has increased from 9.9 Death Rate per Million in 2017 to 10.7 Death Rate per Million in 2019. According to Statista, the number of deaths from diseases of the respiratory system in Spain increased largely from 51,615 in 2017 to 53,687 in 2018. Furthermore, the total market is also expected to be driven by the rising demand for home healthcare. Also, introduction of innovative solutions and rise in utilization of telemonitoring and telemedicine are likely to increase the market growth during the forecast period. However, strict regulatory guidelines leading to delays in product approval impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Oxygen Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to the presence of established market players and high R&D investments. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate over the forecast period 2022-2028 owing to increasing commercialization of O2 therapy equipment and rising prevalence of respiratory diseases.

Major market players included in this report are:
GE Healthcare
Invacare Corporation
CareFusion Corporation
Smiths Medical
HERSILL S.L.
Fisher & Paykel Healthcare Limited
Philips Respironics, Inc.
DeVilbiss Healthcare
Tecno-Gaz Industries
Allied Healthcare Products, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Oxygen Source Equipment
Oxygen Delivery Devices
By Application:
Chronic Obstructive Pulmonary Disease
Asthma
Obstructive Sleep Apnea
Respiratory Distress Syndrome
Others
By End-Use:
Hospitals
Home Healthcare
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Oxygen Therapy Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

GE Healthcare
Invacare Corporation
CareFusion Corporation
Smiths Medical
HERSILL S.L.
Fisher & Paykel Healthcare Limited
Philips Respironics, Inc.
DeVilbiss Healthcare
Tecno-Gaz Industries
Allied Healthcare Products, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.